J. B. Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🔬 Clinical Trials

💄 Cosmetics

💊 Drugstores & Retail Pharmacies

💻 Telehealth

Location

India

Market Cap

USD 3.19 B

Share Price

USD 20.46

Avg Daily Volume

356,666

Change (1 day)

6.14%

Change (1 year)

-5.24%

Change (YTD)

-5.02%

J. B. Chemicals & Pharmaceuticals Limited Operating Income Margin for the year ending March 31, 2025: 48.85%

J. B. Chemicals & Pharmaceuticals Limited Operating Income Margin is 48.85% for the year ending March 31, 2025, a 123.31% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

J. B. Chemicals & Pharmaceuticals Limited Operating Income Margin for the year ending March 31, 2024 was 21.87%, a 16.41% change year over year.
J. B. Chemicals & Pharmaceuticals Limited Operating Income Margin for the year ending March 31, 2024 was 21.87%, a 0.00% change year over year.
J. B. Chemicals & Pharmaceuticals Limited Operating Income Margin for the year ending March 31, 2023 was 18.79%, a -3.87% change year over year.
J. B. Chemicals & Pharmaceuticals Limited Operating Income Margin for the year ending March 31, 2022 was 19.55%, a -19.90% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

NSE: JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

CEO	Mr. Nikhil Ashokkumar Chopra
IPO Date	July 1, 2002
Location	India
Headquarters	Cnergy IT Park
Employees	5,311
Sector	🏥 Health Care
Industries Pharmaceuticals 🔬 Clinical Trials 💄 Cosmetics 💊 Drugstores & Retail Pharmacies 💻 Telehealth

Description

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.